Mara Lorenzi Selected Research

Mara Lorenzi Research Topics

11	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2017 - 07/2002
5	Hyperglycemia 07/2009 - 07/2002
2	Leukostasis 12/2020 - 12/2002
2	Vascular Remodeling 03/2017 - 07/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2011 - 12/2010
2	Type 2 Diabetes Mellitus (MODY) 07/2011 - 12/2002
1	Macular Degeneration (Age-Related Maculopathy) 09/2014
1	Macular Edema 07/2011
1	Inflammation (Inflammations) 07/2009
1	Diabetes Complications 01/2007
1	Cataract (Cataracts) 10/2006

9	Retinaldehyde (Retinal)IBA 12/2020 - 07/2002
5	Aldehyde Reductase (Aldose Reductase)IBA 01/2007 - 02/2003
3	polyolIBA 01/2007 - 02/2003
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2017 - 07/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2007 - 10/2006
2	Streptozocin (Streptozotocin)FDA Link 10/2006 - 09/2004
2	Complement System Proteins (Complement)IBA 10/2006 - 12/2002
1	Ranibizumab (Lucentis)FDA Link 09/2014
1	Biomarkers (Surrogate Marker)IBA 04/2012
1	erucylphosphocholineIBA 04/2012
1	sorbinilIBA 07/2009
1	preemptIBA 07/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2009
1	EnzymesIBA 01/2007
1	FructoseIBA 10/2006
1	CP-744809IBA 10/2006
1	Sorbitol (Yal)FDA Link 10/2006
1	Pharmaceutical PreparationsIBA 12/2005
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2005
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2005
1	Galactose (Galactopyranose)FDA LinkGeneric 09/2004
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 12/2002
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 12/2002
1	Complement Inactivating AgentsIBA 12/2002
1	NF-kappa B (NF-kB)IBA 07/2002

1	Glycemic Control 12/2005